$CLRB

Cellectar Biosciences Achieves FDA Breakthrough Therapy Designation For Novel Cancer Treatment

$CLRB Cellectar Biosciences, Inc. (NASDAQ:CLRB), a pioneering late-stage clinical biopharmaceutical company, has recently been granted a Breakthrough Therapy Designation by…